The global particle size analysis market size is expected to grow from USD 366.3 million in 2020 to USD 502.3 million by 2026 at a CAGR of 5.4%.
Market growth is driven largely by factors such as the expansion of research activities in the field of nanotechnology, the growing investment in pharmaceutical R&D, and strict guidelines for product quality control in all industries. However, heavy import duties on particle size analysis in developing countries and the limits on the degree of particle classification are major factors that are expected to hinder the growth of this market during climate change.
By technology, the particle size analysis market is divided into laser diffraction, dynamic light scattering, imaging, Coulter principle, nanoparticle tracking analysis, and other technologies. The Nanoparticle Tracking Analysis (NTA) segment is expected to witness the highest growth in the forecast period. The significant growth of this phase is due to the improved use of these particle analysts and the growing research activities in the field of nanotechnology. In addition, NTA is widely used in biopharma and biotech applications. The expansion of R&D activities in the biopharmaceutical industry is expected to stimulate market growth for this sector.
By type, the particle size analysis is divided into two main types - dynamic and static. Factors such as high-quality images/image resolution, better image recognition, user-friendliness, individual sample measurements, and speed analysis contribute to the growth of the segment of dynamic imaging.
The healthcare sector had the largest share in the particle size analysis market, by end users, in 2020. A large proportion of the healthcare sector may be due to increased R&D costs for pharmaceutical companies in developing Asian countries and unmet needs for patients with certain medical conditions (such as cancer) who are reviving pharmacological research studies. In addition, government support for drug development, the growing number of biotechnology companies, the technological advancement of major players to provide particle size technology, a growing number of the company's efforts to increase customer awareness of new analytical solutions available for particle formations, of biopharmaceutical and discovery drug.
Asia Pacific is the largest revenue-generating region in the particle size analysis market. Factors such as increased awareness of nanotechnology, the availability of key markets for nanotechnology, the implementation of government reforms and regulations to improve product quality, high-quality industry standards, and the steady movement of manufacturing and R&D pharmaceutical activities from advanced markets to Asian markets acting as a driving factor for the Asia Pacific particle size analysis market.
The vendors operating in the global particle size analysis market include Beckman Coulter (UK), Malvern Panalytical (UK), HORIBA (Japan), MICROTRAC MRB, (US), Shimadzu Corporation (Japan), Izon Science (UK), Bettersize Instruments (China), Micromeritics Instrument Corporation (US), Sympatec (Germany), TSI (US), FRITSCH (Germany), Brookhaven Instruments, (US), Anton Paar (Austria), AimSizer (China), and LS Instruments AG (Switzerland).